Biohaven BHVN
NYSE BHVN
$13.51 +0.22 (+1.66%)
As of: Sep 30, 2026 · 2:45 PM EDT

Biohaven (BHVN) Non-Current Debt (2025 - 2026)

Updated

Biohaven's Non-Current Debt was $259.48 million in Q2 2026, up 0.9% from $257.07 million a year earlier and up 7.3% from the prior quarter.

Analysis

Biohaven (BHVN) Non-Current Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Debt at Biohaven came in at $238.9 million.

  • Quarterly Non-Current Debt has moved between $238.9 million (Q4 2025) and $268.27 million (Q3 2025) over five years.
  • Per Business Quant data, BHVN's Non-Current Debt in the three quarters before Q2 2026 was $241.91 million (Q1 2026), $238.9 million (Q4 2025) and $268.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 37.34 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 62.48 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -108.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Biohaven 2.01 Bn 815.01 Mn - 259.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 259.48 Mn
Mar 31, 2026 241.91 Mn
Dec 31, 2025 238.90 Mn
Sep 30, 2025 268.27 Mn
Jun 30, 2025 257.07 Mn
API Access

Biohaven Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=BHVN&period=max&api_key=YOUR_API_KEY